• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病:超越静脉注射免疫球蛋白和阿司匹林

Kawasaki Disease: Beyond IVIG and Aspirin.

作者信息

Moussa Taha, Wagner-Weiner Linda

出版信息

Pediatr Ann. 2019 Oct 1;48(10):e400-e405. doi: 10.3928/19382359-20190919-01.

DOI:10.3928/19382359-20190919-01
PMID:31609999
Abstract

Kawasaki disease (KD) is a vasculitis syndrome of unknown etiology, affecting medium-sized vessels and occurring primarily in young children. It is a self-limited illness classically presenting with fever, conjunctivitis, mucocutaneous lesions, and cervical adenopathy. However, vasculitis of coronary arteries with aneurysm formation may occur, leading to morbidity and rarely mortality. Prompt diagnosis of KD is essential as early treatment with intravenous immune globulin (IVIG) decreases the occurrence and severity of coronary vasculitis. This article reviews the clinical characteristics of KD, laboratory assessment, echocardiogram findings, and recommended initial medical therapy. Complications of KD are discussed, including KD refractory to IVIG, the presence of shock or macrophage activation syndrome (MAS), and short/long-term cardiac sequelae. The medical management of these complications is reviewed. Although improved treatment of KD has resulted in a decrease of coronary artery vasculitis over the past 3 decades, KD remains the most common cause of acquired heart disease in children. [Pediatr Ann. 2019;48(10):e400-e405.].

摘要

川崎病(KD)是一种病因不明的血管炎综合征,主要累及中等大小血管,好发于幼儿。它是一种自限性疾病,典型表现为发热、结膜炎、皮肤黏膜病变和颈部淋巴结肿大。然而,可能会发生伴有动脉瘤形成的冠状动脉血管炎,导致发病,甚至罕见情况下会导致死亡。及时诊断KD至关重要,因为早期静脉注射免疫球蛋白(IVIG)治疗可降低冠状动脉血管炎的发生率和严重程度。本文综述了KD的临床特征、实验室评估、超声心动图表现以及推荐的初始药物治疗。还讨论了KD的并发症,包括对IVIG难治的KD、休克或巨噬细胞活化综合征(MAS)的存在以及短期/长期心脏后遗症。并对这些并发症的药物治疗进行了综述。尽管在过去30年中,KD治疗的改善使冠状动脉血管炎有所减少,但KD仍然是儿童后天性心脏病的最常见原因。[《儿科年鉴》。2019年;48(10):e400 - e405。]

相似文献

1
Kawasaki Disease: Beyond IVIG and Aspirin.川崎病:超越静脉注射免疫球蛋白和阿司匹林
Pediatr Ann. 2019 Oct 1;48(10):e400-e405. doi: 10.3928/19382359-20190919-01.
2
Incomplete Kawaski disease: are we missing it?不完全川崎病:我们是否漏诊了?
J Pak Med Assoc. 2009 Jan;59(1):42-3.
3
High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.高剂量阿司匹林与贫血相关,且对川崎病的疾病转归无益处。
PLoS One. 2015 Dec 10;10(12):e0144603. doi: 10.1371/journal.pone.0144603. eCollection 2015.
4
Recurrent Kawasaki disease.川崎病复发。
Indian J Pediatr. 2009 Aug;76(8):848-9. doi: 10.1007/s12098-009-0157-3. Epub 2009 May 27.
5
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.多中心、随机、开放标签、盲终点评估的皮质类固醇加静脉注射免疫球蛋白(IVIG)和阿司匹林与 IVIG 和阿司匹林预防川崎病(KD)冠状动脉瘤(CAA)的试验:KD CAA 预防(KD-CAAP)试验方案。
Trials. 2023 Jan 26;24(1):60. doi: 10.1186/s13063-022-07051-9.
6
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病的诊断、治疗及长期管理:美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎及川崎病委员会为卫生专业人员发布的声明
Pediatrics. 2004 Dec;114(6):1708-33. doi: 10.1542/peds.2004-2182.
7
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病的诊断、治疗及长期管理:美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎及川崎病委员会给卫生专业人员的声明
Circulation. 2004 Oct 26;110(17):2747-71. doi: 10.1161/01.CIR.0000145143.19711.78.
8
Kawasaki disease.川崎病。
Pediatr Clin North Am. 2012 Apr;59(2):425-45. doi: 10.1016/j.pcl.2012.03.009.
9
The diagnosis and management of Kawasaki disease.川崎病的诊断与管理
J Paediatr Child Health. 2005 Mar;41(3):87-93. doi: 10.1111/j.1440-1754.2005.00555.x.
10
Kawasaki disease: a comprehensive review of treatment options.川崎病:治疗选择的全面综述
J Clin Pharm Ther. 2015 Dec;40(6):620-5. doi: 10.1111/jcpt.12334. Epub 2015 Nov 7.

引用本文的文献

1
Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial.静脉注射甲泼尼龙冲击疗法与静脉注射免疫球蛋白预防川崎病患儿冠状动脉疾病的随机对照试验
Cureus. 2022 Jun 23;14(6):e26252. doi: 10.7759/cureus.26252. eCollection 2022 Jun.
2
[Pediatric expert consensus on the application of aspirin in Kawasaki disease].[川崎病应用阿司匹林的儿科专家共识]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Jun 15;24(6):597-603. doi: 10.7499/j.issn.1008-8830.2203190.